We report a previously unreported triad in this context: euDKA precipitated by influenza A with secondary methicillin-susceptible S. aureus (MSSA) pneumonia in a patient on long-term SGLT2 inhibitor therapy. Here, SLC5A2 is linked to susceptibility to pneumonia measurement.